Parkifen Tablet 2 mg contains Trihexyphenidyl Hydrochloride, a centrally acting anticholinergic agent used primarily in the management of Parkinson’s disease and drug-induced extrapyramidal symptoms (EPS). This tablet helps restore the balance of neurotransmitters in the brain, improving motor control, reducing tremors, rigidity, and muscle stiffness, and enhancing overall quality of life for patients with movement disorders.
Trihexyphenidyl works by blocking the action of acetylcholine in the central nervous system. In conditions like Parkinson’s disease, dopamine deficiency leads to an imbalance between dopamine and acetylcholine, resulting in abnormal muscle contractions and tremors. Parkifen Tablet helps correct this imbalance, thereby alleviating symptoms such as tremors, rigidity, and involuntary movements.
The 2 mg dose is suitable for initial therapy, titration, or long-term maintenance, depending on patient response and tolerability. Parkifen is particularly beneficial for patients experiencing early or mild Parkinsonian symptoms, or those who develop extrapyramidal side effects from antipsychotic medications.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active Ingredient – Trihexyphenidyl Hydrochloride 2 mg: Centrally acting anticholinergic for managing Parkinson’s disease and EPS.
Reduces Tremors and Rigidity: Improves muscle control and movement coordination.
Relieves Extrapyramidal Symptoms: Manages drug-induced stiffness, spasms, and involuntary movements.
Enhances Motor Function: Improves daily activity performance and quality of life.
Easy Oral Administration: Convenient tablet for regular dosing.
Parkifen Tablet 2 mg is indicated for:
Management of Parkinson’s disease (idiopathic and secondary)
Control of tremors, muscle rigidity, and bradykinesia in Parkinsonism
Treatment of drug-induced extrapyramidal symptoms (EPS) caused by antipsychotic therapy
Symptomatic relief of dystonia and other movement disorders
Trihexyphenidyl in Parkifen works through the following mechanism:
Anticholinergic Effect: Blocks muscarinic acetylcholine receptors in the central nervous system.
Neurotransmitter Balance: Reduces acetylcholine activity, counteracting dopamine deficiency in Parkinson’s disease.
Symptom Relief: Alleviates tremors, rigidity, muscle stiffness, and involuntary movements associated with Parkinsonism or EPS.
This selective action provides targeted symptom control while improving motor coordination and patient mobility.
Adults: Typically start with 1–2 mg daily, divided into 1–2 doses, and gradually increase based on response and tolerability.
Maximum daily dose should not exceed prescribed limits; titration should be supervised by a physician.
Take orally, preferably with meals to reduce gastrointestinal discomfort.
Dose adjustments may be required in elderly patients or those with renal/hepatic impairment.
Parkifen Tablet 2 mg is generally well tolerated but may cause anticholinergic side effects such as dry mouth, blurred vision, constipation, urinary retention, or dizziness.
Use with caution in patients with glaucoma, gastrointestinal obstruction, urinary retention, or cardiac conditions.
Avoid abrupt discontinuation, as this may worsen Parkinsonian symptoms.
Store in a cool, dry place below 25°C, protected from light, and out of reach of children.
Consult a healthcare professional if side effects persist or worsen.
Parkifen Tablet 2 mg provides safe, effective, and convenient management of Parkinson’s disease and drug-induced extrapyramidal symptoms, improving mobility, motor control, and overall quality of life.
Login Or Registerto submit your questions to seller
No none asked to seller yet